Different inhibitory effect of fluvoxamine on omeprazole metabolism between CYP2C19 genotypes

AIMS: Omeprazole is mainly metabolized by the polymorphic cytochrome P450 (CYP) 2C19. The inhibitory effect of fluvoxamine, an inhibitor of CYP2C19 as well as CYP1A2, on the metabolism of omeprazole was compared between different genotypes for CYP2C19. METHODS: Eighteen volunteers, of whom six were...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yasui-Furukori, Norio, Takahata, Takenori, Nakagami, Taku, Yoshiya, Gen, Inoue, Yoshimasa, Kaneko, Sunao, Tateishi, Tomonori
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Science Inc 2004
Matèries:
Drug Interactions
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1884483/
https://ncbi.nlm.nih.gov/pubmed/15025747
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2004.02047.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars